"XERIS Pharmaceuticals, Inc. - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
XERIS Pharmaceuticals, Inc. (XERIS) is a biopharmaceutical company. The company develops injectables for the treatment of diabetes, epilepsy, and immunology. Its products include xerisol glucagon and xeriject diazepam. XERIS's proprietary delivery system offers several advantages over existing needle and needle-free formulations which includes 100 to 1000-fold Lower Injection Volume, predictable pharmacokinetics, easy-to-use, broad dosing flexibility and among others. XERIS is headquartered in Austin, Texas, the US.
View full press release